Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a needed cup of stimulation. Our choice today is ginseng honey, a favorite from our pantry. Meanwhile, here is the latest menu of tidbits to help you on your way. We hope you conquer the world and have a wonderful day. And as always, please do stay in touch. …
About 14% of employers in the U.S. have already or plan to drop coverage of GLP-1 drugs in 2027, as companies see rising health care costs , Reuters notes, citing a survey by the Business Group on Health. Two-thirds of employers reported rising use of the medicines while the share of employers covering GLP-1 weight loss drugs dropped from 72% in 2025 to 60% in 2026. Pharmacy costs made up 25% of employer health care spending and are expected to rise by 12% in 2027, unchanged from the year prior. PepsiCo, for example, is dropping coverage, says Bloomberg News .
The number of people working in Massachusetts’ renowned biotech sector fell last year, the first time that’s happened since at least 2002 , The Boston Globe writes. The state’s biopharma workforce shrank by about 3,600 employees in 2025, to a total of 113,503, as industry headwinds and uncertainty about federal funding for scientific research battered the sector, according to the annual “ industry snapshot ” by the Massachusetts Biotechnology Council trade group. Compared to 2024, the workforce declined by 3.1%.
Continue to STAT+ to read the full story…